Colgate-Palmolive Company

(New York Stock Exchange)
Back to all articles
Bullish +55

Colgate-Palmolive stock holds recent gains as institutional buying and dividend support sentiment - AD HOC NEWS

AI-generated analysis

📈 CL stock closed at $92.26 on June 29, 2026, up roughly 16.8% over the past year with extended-hours indications in the low $90s.

🏦 AMI Asset Management Corp increased its position by 17.8% in Q1 2026, adding 75,262 shares to a total stake of 498,079 valued at ~$42.45 million.

💰 The company declared a quarterly dividend scheduled for payment on August 14, 2026, supporting its defensive income profile.

📊 Recent quarterly results showed EPS of $0.97, beating the consensus forecast of $0.94 by $0.03.

📈 Revenue increased by approximately 8.4% year-over-year in the latest quarter, indicating volume growth and pricing power.

🛡️ Brokerages collectively assign an average recommendation of 'Moderate Buy', signaling Wall Street views the shares as solid.

🌍 The company maintains a strong global presence with flagship Colgate oral care products and significant positions in personal care via the Palmolive brand.

🇮🇳 Localized product lines in emerging markets like India and Australia help capture growth while premium positioning supports margins in developed regions.

Bullish Signals
  • Stock price has appreciated roughly 16.8% over the past year, trading near recent highs on the NYSE.
  • Significant institutional inflows occurred in Q1 2026, with AMI Asset Management Corp increasing its stake by 17.8%.
  • The company beat earnings per share expectations, reporting $0.97 versus a consensus forecast of $0.94.
  • Revenue grew 8.4% year-over-year, demonstrating the ability to offset input cost pressures with volume and pricing power.
  • A confirmed quarterly dividend payable on August 14, 2026, reinforces its appeal as a defensive income stock.
  • Analyst consensus is 'Moderate Buy', indicating broad institutional confidence in the company's fundamentals.
Full Analysis
Colgate-Palmolive (CL) shares are trading near recent highs on the NYSE, supported by fresh institutional buying and a confirmed quarterly dividend. The stock closed at $92.26 on June 29, 2026, representing a gain of roughly 16.8% over the past year, with pre-market trading showing modest strength in the low $90s. Institutional interest has increased significantly in the first quarter of 2026, highlighted by AMI Asset Management Corp expanding its position by 17.8%. This firm added 75,262 shares to a total stake of 498,079, valued at approximately $42.45 million, which now represents about 2.7% of the fund's portfolio and ranks as its 14th largest holding. The company recently declared a quarterly dividend payable on August 14, 2026, reinforcing its status as a defensive consumer staples stock for income-focused investors. Financially, Colgate-Palmolive reported earnings per share of $0.97 in its most recent quarter, beating the consensus forecast of $0.94 by $0.03, while revenue grew 8.4% year-over-year. Analysts collectively maintain an average recommendation of 'Moderate Buy' for the stock, viewing it as a solid defensive name rather than a speculative play. Operationally, the company leverages its global portfolio, including the flagship Colgate toothpaste franchise and the Palmolive brand family in personal and home care, to maintain pricing power and capture growth across both developed and emerging markets.